T46.1X
Poisoning by, adverse effect of and underdosing of calcium-channel blockers
Clinical Classification Guidelines
Medical Intelligence & Overview
Calcium-channel blockers are medications commonly used to treat conditions like high blood pressure and certain heart problems. However, in cases of overdose or adverse reactions, they can cause poisoning, which may lead to serious health complications. This guide provides a patient-friendly overview of calcium-channel blocker poisoning, including its causes, symptoms, diagnosis, and general treatment options.
Causes & Symptoms
Clinical Causes: Accidental overdose of calcium-channel blocker medications Intentional overdose in suicide attempts Incorrect dosage administration by patients or caregivers Adverse effects due to inappropriate use or interactions with other drugs
Key Symptoms: Low blood pressure (hypotension) Dizziness or lightheadedness, especially upon standing Rapid or slow heartbeat (arrhythmias) Nausea and vomiting Weakness or fatigue Confusion or altered mental state Respiratory depression in severe cases Seizures or unconsciousness in extreme instances
Diagnostic & Treatment
Diagnosis Path: Diagnosing calcium-channel blocker poisoning involves a combination of medical history, physical examination, and laboratory tests. Healthcare providers may review medication history to identify recent or excessive intake. Blood tests can detect the presence and levels of the medication, assess organ function, and check electrolyte balances. Electrocardiograms (ECGs) are often performed to evaluate heart rhythm abnormalities associated with overdose.
Treatment Protocols: Managing calcium-channel blocker poisoning typically requires prompt medical intervention. Treatment strategies may include:
Clinical Advice & FAQs
Billing Guidance
Is T46.1X a billable ICD-10 code?
Yes, T46.1X is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T46.1X?
Clinical documentation must specify the nature of Poisoning by, adverse effect of and underdosing of calcium-channel blockers and any associated comorbidities for accurate reporting.
Cite this Clinical Reference